Follow The Filings

STOCK Act disclosures

TBPH Theravance Biopharma, Inc.

Members of Congress who traded or hold Theravance Biopharma, Inc., from their STOCK Act disclosures. None of the 13F managers we track hold it, so this page covers Congress only. TBPH earnings.

  • 1 members traded it since Nov 22, 2023
  • 0 / 1 buys / sales
  • 0 held it at year end
  • Mar 24, 2025 latest trade

Trades

1 trade since Nov 22, 2023, newest filings first

  1. George WhitesidesD-CA-27House
    TBPHTheravance Biopharma, Inc. - Ordinary Shares
    Sell
    $15K–$50K
    Traded Mar 24, 2025Filed Apr 23, 2025 30d

Amounts are the ranges members disclose. Trades cover the last three years; holdings come from each member's latest annual report. See all Congress trades and how we read these reports.